Vidac Pharma Holding PLC Sustainability Reports

Vidac Pharma Holding PLC operates as a clinical-stage biopharmaceutical company. It discovers and develops first-in-class medicines designed to modify the hyper-glycolytic tumor microenvironment for oncology and onco-dermatology diseases.

Sector: Finance & insurance

Country: United Kingdom

Exchange: Börse Hamburg

LEI: 875500BCH1T6XX5EUG13

FIGI: BBG01H0BB0P6

4 reports from 2021 to 2024

• Vidac Pharma Holding PLC 2024 Annual Report and Financial Statements
• Vidac Pharma Holding PLC 2023 Annual Report and Financial Statements
• Vidac Pharma Holding PLC 2022 Group Strategic Report, Report of Directors and Consolidated Financial Statements
• Vidac Pharma Holding PLC 2021 Balance Sheet